(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Ajovy, an injection made by Israeli drugmaker Teva ...

The stock slipped 3.5% postmarket after the chip maker reported adjusted earnings per share in line with estimates.

Amgen on Tuesday posted quarterly financial results that beat Wall Street expectations as a 9% increase in product sales ...

Amgen (NASDAQ:AMGN) surpasses Q2 earnings and revenue expectations with a 9.4% revenue growth. Read more here.

Amgen crushed second-quarter forecasts late Tuesday. But Amgen stock fell in late-afternoon trading following its report.

Amgen reported higher profit and revenue in the second quarter after 15 of the biotechnology company's products saw at least double-digit sales growth. The Thousand Oaks, Calif.-based biotechnology ...

Amgen Inc (NASDAQ:AMGN) shares held near flat in after-hours trading Tuesday despite posting better-than-expected quarterly ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

The results topped Wall Street expectations. The average estimate of 13 analysts surveyed by Zacks Investment Research was ...

These three dividend payers have an average yield of 4.5%. David Harrell: Hi, I’m David Harrell, editor of the Morningstar ...